BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35064332)

  • 1. Is There a Relationship Between TILs and Regression in Melanoma?
    Morrison S; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj B; Kosiorek HE; Zager JS; Messina JL; Mozzillo N; Schneebaum S; Han D;
    Ann Surg Oncol; 2022 May; 29(5):2854-2866. PubMed ID: 35064332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
    Morrison SL; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj BA; Kosiorek HE; Zager JS; Sondak VK; Messina JL; Mozzillo N; Schneebaum S; Han D;
    Cancer; 2022 Apr; 128(7):1418-1428. PubMed ID: 35103302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological regression in melanoma: impact on sentinel lymph node status and survival.
    Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
    Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
    Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
    Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
    Grotz TE; Vaince F; Hieken TJ
    Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression and Sentinel Lymph Node Status in Melanoma Progression.
    Letca AF; Ungureanu L; Şenilă SC; Grigore LE; Pop Ş; Fechete O; Vesa ŞC; Cosgarea R
    Med Sci Monit; 2018 Mar; 24():1359-1365. PubMed ID: 29507279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Granzyme B positive tumour-infiltrating lymphocytes in primary melanoma excisional biopsies is strongly associated with the presence of sentinel lymph node metastasis.
    van Houdt IS; Sluijter BJ; van Leeuwen PA; Moesbergen LM; Hooijberg E; Meijer CJ; de Gruijl TD; Oudejans JJ; Boven E
    Cell Oncol; 2009; 31(5):407-13. PubMed ID: 19759420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.
    Straker RJ; Krupp K; Sharon CE; Thaler AS; Kelly NJ; Chu EY; Elder DE; Xu X; Miura JT; Karakousis GC
    Ann Surg Oncol; 2022 Aug; 29(8):5207-5216. PubMed ID: 35301610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Procedure, Nuclear Imaging and Clinicopathological Characteristics as Predictive Factors for Sentinel Lymph Node Metastasis in Cutaneous Melanoma: A Single-Center Analysis.
    Jaukovic L; Rajović M; Kandolf Sekulovic L; Radulovic M; Stepic N; Mijuskovic Z; Petrov N; Ajdinovic B
    Ann Plast Surg; 2018 Jul; 81(1):80-86. PubMed ID: 29762449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients.
    Tas F; Erturk K
    Cancer Invest; 2017 Sep; 35(8):501-505. PubMed ID: 28799813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
    Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
    JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
    Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
    Tas F; Erturk K
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.
    Duprat JP; Brechtbülh ER; Costa de Sá B; Enokihara M; Fregnani JH; Landman G; Maia M; Riccardi F; Belfort FA; Wainstein A; Moredo LF; Steck H; Brandão M; Moreno M; Miranda E; Santos ID
    PLoS One; 2016; 11(2):e0148160. PubMed ID: 26859408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.